US EditionBiologics and Biosimilars Differ in Composition Due to Variability in Biological Manufacturing Processes
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Biologics and Biosimilars Differ in Composition Due to Variability in Biological Manufacturing Processes
Biopharmaceutical products have significantly transform […] The post Biologics and Biosimilars Differ in Composition Due to Variability in Biological Manufacturing Processes first appeared on GeneOnline News. The post Biologics and Biosimilars Differ in Composition Due to Variability in Biological Manufacturing Processes appeared first on GeneOnline News.
Likarda and Axio team up to tackle biologic manufacturing and delivery
Biomanufacturing firm Axio BioPharma partners with drug delivery specialist Likarda to integrate Core-Shell Spherification technology with scalable manufacturing capabilities, accelerating biologics development timelines and enhancing drug stability, efficacy, and patient experience through innovative encapsulation methods and streamlined production processes.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
